Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation.
Pei-Sheng LeeYi-Shiou ChiouChi-Tang HoMin-Hsiung PanPublished in: BioFactors (Oxford, England) (2017)
Epigenetic mechanisms are essential in regulating normal cellular functions and play an important role during the disease developmental stages. However, aberrant epigenetic mechanisms may lead to pathological consequences such as cancer, neurological disorders, bone and skeletal diseases, cardiovascular dysfunction, and metabolic syndrome. The molecular mechanisms of epigenetic modification include DNA methylation, histone modification (acetylation, methylation and phosphorylation), and microRNAs (miRNAs). Unlike genetic modifications, epigenetic states of genes are reversible and can be altered by certain intrinsic and extrinsic factors. In the past few decades, accumulated evidence shows that dietary phytochemicals with chemopreventive effects are also potent epigenetic regulators. Resveratrol and pterostilbene are stilbenoids, which have been reported to have anti-cancer, anti-inflammatory, anti-lipid, and anti-diabetic properties. Stilbenoids are also reported to improve cardiovascular disease. By altering DNA methylation and histone modification or by modulating miRNA expression, resveratrol, and pterostilbene become potent epigenetic modifiers. In this review, we summarize these studies and underlying mechanisms of resveratrol and pterostilbene and their influence on epigenetic mechanisms. © 2017 BioFactors, 44(1):26-35, 2018.
Keyphrases
- insulin resistance
- dna methylation
- metabolic syndrome
- genome wide
- adipose tissue
- gene expression
- type diabetes
- cardiovascular disease
- anti inflammatory
- copy number
- uric acid
- papillary thyroid
- poor prognosis
- cancer therapy
- oxidative stress
- signaling pathway
- cardiovascular risk factors
- blood brain barrier
- wound healing
- brain injury
- squamous cell
- body composition
- soft tissue